Laboratory characteristics of direct antiglobulin test–positive anemia in patients with newly diagnosed multiple myeloma
Laboratory Medicine · 04.08.2026 · 57 (5)
DOI: 10.1093/labmed/lmag044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Laboratory Medicine, online erschienen am 04.08.2026. Verfasst von Yutong Zheng und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Multiple Myeloma, Coombs Test, Anemia. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
Introduction
This study retrospectively characterized the laboratory features of direct antiglobulin test (DAT)–positive anemia in newly diagnosed multiple myeloma (MM) and explored associated immunologic alterations to better understand MM-related immune dysregulation.
Methods
We enrolled 77 patients with newly diagnosed MM admitted to our hospital between 2021 and 2025. Based on DAT results, patients were assigned to a DAT-positive group (n = 52) or a DAT-negative group (n = 25). Clinical characteristics, laboratory parameters, and peripheral blood T-cell subsets were compared between groups.
Results
Monoclonal immunoglobulin (M protein) isotype distribution was statistically significantly different between groups (P < .001), with immunoglobulin G predominating in the DAT-positive group (88.46%). Compared with the DAT-negative group, DAT-positive patients had lower albumin, sodium, and potassium levels as well as a lower albumin to globulin ratio but higher levels of globulin and ferritin as well as higher absolute lymphocyte counts (all P < .05). Flow cytometric analysis showed increased T-cell–related parameters, particularly CD8-positive T cells, in the DAT-positive group, whereas reduced natural killer–cell and B-cell counts were more common in the DAT-negative group.
Discussion
The observed laboratory profile suggested a more pronounced state of inflammatory or immune activation and electrolyte disturbances, highlighting the need for improved clinical recognition and detection of potential immune-mediated red blood cell injury, hemolytic predisposition, and related immune abnormalities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
- Department of Transfusion Medicine, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
- Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Zitieren
APA
Zheng, Y., Zhao, Y., Wu, D., Zong, H., Huo, H., Geng, C., Li, S., He, Y., Liu, Y., Li, H., Liu, J., Zhao, Y., Liu, X., & Lv, J. (2026). Laboratory characteristics of direct antiglobulin test–positive anemia in patients with newly diagnosed multiple myeloma. Laboratory Medicine, 57(5). https://doi.org/10.1093/labmed/lmag044
Vancouver
Zheng Y, Zhao Y, Wu D, Zong H, Huo H, Geng C, et al. Laboratory characteristics of direct antiglobulin test–positive anemia in patients with newly diagnosed multiple myeloma. Laboratory Medicine. 2026;57(5). doi:10.1093/labmed/lmag044
BibTeX
@article{Zheng2026,
author = {Zheng, Yutong and Zhao, YanTian and Wu, Di and Zong, Hong and Huo, Hong and Geng, ChuanYing and Li, Sha and He, YongQi and Liu, YinChu and Li, HongShuai and Liu, JunQin and Zhao, YaJun and Liu, Xin and Lv, Juan},
title = {Laboratory characteristics of direct antiglobulin test–positive anemia in patients with newly diagnosed multiple myeloma},
journal = {Laboratory Medicine},
year = {2026},
volume = {57},
number = {5},
doi = {10.1093/labmed/lmag044}
}
EUVIMED